Medizone International Inc. (MZEI)

Other OTC - Other OTC Delayed Price. Currency in USD
0.07+0.01 (+9.70%)
As of 1:53 PM EDT. Market open.
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close0.07
Bid0.00 x
Ask0.00 x
Day's Range0.07 - 0.08
52wk Range0.04 - 0.11
1y Target EstN/A
Market Cap27.19M
P/E Ratio (ttm)-12.25
Avg Vol (3m)144,755
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • PR Newswire3 months ago

    Medizone International Selects Cogmedix as Medical Device Manufacturing Services Provider

    WORCESTER, Mass., July 19, 2016 /PRNewswire/ -- Cogmedix, a wholly owned subsidiary of Coghlin Companies Inc., established in 1885, is proud to announce that Medizone International, Inc., (MZEI) has selected Cogmedix as their turnkey medical device manufacturing services provider for the AsepticSure® Generation III hospital disinfection system. Cogmedix Executive Vice President and General Manager, Matt Giza, shared Marshall's enthusiasm.  "Cogmedix is very excited to be a part of the impact AsepticSure® will have across the globe.

  • PR Newswire4 months ago

    AsepticSure's South American Distributor Places Order

    SAN FRANCISCO, June 20, 2016 /PRNewswire/ -- Medizone International, Inc. (MZEI).   GYD S.A., Medizone's exclusive distributor for our AsepticSure® hospital disinfection system in Chile, Brazil, Colombia and Peru, intends to offer both a service model and sales model for AsepticSure distribution. With regulatory approval progressing, GYD S.A. has placed an initial order for the first three Generation III AsepticSure systems. While the roll out of AsepticSure distribution throughout South America will be gradual, the principals of GYD S.A. have been successful twice before using the same business model in establishing distribution channels throughout the continent.  Given the acute need to address major hospital based infection issues on the continent, including evidence of super bugs in Rio with the up-coming Olympic Games, the ability to greatly reduce these infection threats in the health care community is gaining attention.  Medizone believes GYD S.A.'s proven business model will be successful again.

  • PR Newswire4 months ago

    AsepticSure Receives EU Patent Approval for its Bio-Terrorism Counter Measures Application

    SAN FRANCISCO, June 13, 2016 /PRNewswire/ -- Medizone International, Inc. (OTCQB: MZEI) is pleased to announce that its unprecedented room disinfection technology, AsepticSure®, has been granted patent ...